Loading...

FITC anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_FITC
C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
  • RA3-6B2_FITC
    C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103205 50 µg 24€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103206 500 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  2. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  3. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  4. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  5. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  6. Zaman R, et al. 2021. Immunity. :. PubMed
  7. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  8. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  9. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  10. Israelow B, et al. 2020. bioRxiv. . PubMed
  11. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  12. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  13. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  14. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  15. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  16. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  17. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  18. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  19. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  20. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  21. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  22. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  23. Dong L, et al. 2021. Cancer Cell. . PubMed
  24. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  25. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  26. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  27. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  28. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  29. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  30. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  31. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  32. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  33. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  34. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  35. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  36. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  37. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  38. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  39. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  40. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  41. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  42. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  43. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  44. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  45. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  46. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  47. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  48. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  49. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  50. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  51. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  52. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  53. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  54. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  55. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  56. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  57. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  58. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  59. Köchl R, et al. 2020. Elife. 9:00. PubMed
  60. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  61. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  62. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  63. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  64. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  65. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  66. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  67. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  68. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  69. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  70. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  71. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  72. Hutter K, et al. 2020. FEBS J. . PubMed
  73. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  74. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  75. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  76. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  77. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  78. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  79. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  80. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  81. Roy K, et al. 2019. Immunity. 50:616. PubMed
  82. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  83. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  84. Li H, et al. 2020. Nature. 584:274. PubMed
  85. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  86. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  87. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  88. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  89. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  90. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  91. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  92. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  93. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  94. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  95. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  96. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  97. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  98. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  99. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  100. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  101. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  102. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  103. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  104. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  105. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  106. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  107. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  108. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  109. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  110. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  111. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  112. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  113. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  114. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  115. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  116. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  117. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  118. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  119. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  120. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  121. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  122. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  123. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  124. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  125. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  126. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  127. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  128. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  129. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  130. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  131. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  132. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  133. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  134. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  135. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  136. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  137. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  138. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  139. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  140. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  141. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  142. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  143. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  144. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  145. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID
AB_312990 (BioLegend Cat. No. 103205)
AB_312991 (BioLegend Cat. No. 103206)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV™ 395 anti-mouse/human CD45R/B220 RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04.25.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account